• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS US CORP. PRECISE PRO RX; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS US CORP. PRECISE PRO RX; STENT, CAROTID Back to Search Results
Catalog Number PC1040RXC
Device Problem Fracture (1260)
Patient Problems Neck Pain (2433); Swelling/ Edema (4577)
Event Date 06/07/2018
Event Type  malfunction  
Manufacturer Narrative
The product history review is expected but has not been completed.Additional information is pending and will be submitted within 30 days upon receipt.
 
Event Description
As reported, the patient experienced a painful bulge in her neck where an 8mm x 40mm x 135cm precise pro rx nitinol carotid stent was placed.The stent was found to be splitting.This occurred 3 weeks after implantation.The device will not be returned for evaluation.
 
Manufacturer Narrative
The patient experienced a painful bulge in her neck where an 8mm x 40mm x 135cm precise pro rx nitinol carotid stent was placed.The stent was found to be splitting.This occurred 3 weeks after implantation.The device was not returned for analysis.A product history record (phr) review of lot 17706484 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.Without the return of the device for analysis and based on the information provided, the reported ¿stent-~ fractured could not be confirmed and the exact root cause could not be determined.It is difficult to draw a clinical conclusion between the device and the events based on the information available.However, it is probable that handling and procedural factors such as vessel characteristics as well as the user¿s interaction with the device may have contributed to the reported neck swelling/ stent fracture.According to the instructions for use (ifu) ¿post-deployment stent dilatation: while using fluoroscopy, withdraw the entire delivery system as one unit, over the guidewire and out of the body.Remove the delivery device from the guidewire.Note: if any resistance is met during delivery system withdrawal, advance the outer sheath until the outer sheath marker contacts the catheter tip and withdraw the system as one unit.(do not remove guidewire.) using fluoroscopy, visualize the stent to verify full deployment.If incomplete expansion exists within the stent at any point along the lesion, post deployment balloon dilatation (standard pta technique) can be performed.The act of stent implantation produces intended damage to the intima of the vessel wall in order to remodel the wall and reestablish patency of the vessel.The disruption of the intimal layers triggers the immune system to heal the damaged areas, thus activating the clotting mechanism as well as the inflammatory response.The combination of inflammatory response and clotting cascade can lead to thrombus formation inside of the stent and instigate vessel remodeling around the stent, producing gaps between the stent and the vessel wall.It should be noted that pharmacological factors including patient compliance with medication regimen and discontinuation of anti-platelet therapy (although unknown) as well as patient history: smoking, diabetes, family history, hypertension, hyperlipidemia, prior cad, obesity (although unknown) may have additionally led to the reported event.Neither the phr review nor the information available suggests a design or manufacturing related cause could be related to the manufacturing process of the unit.Therefore, no corrective or preventive actions will be taken.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRECISE PRO RX
Type of Device
STENT, CAROTID
Manufacturer (Section D)
CORDIS US CORP.
14021 nw 60 avenue
miami lakes, florida 33014
Manufacturer (Section G)
CORDIS US CORP.
14021 nw 60 avenue
miami lakes, florida 33014
Manufacturer Contact
karla castro
14021 nw 60 avenue
miami lakes, florida 33014
7863138372
MDR Report Key17015204
MDR Text Key316209834
Report Number9616099-2023-06504
Device Sequence Number1
Product Code NIM
UDI-Device Identifier10705032036559
UDI-Public(01)10705032036559(17)190731(10)17706484
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 07/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/26/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2019
Device Catalogue NumberPC1040RXC
Device Lot Number17706484
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received07/04/2023
Was Device Evaluated by Manufacturer? No
Date Device Manufactured08/15/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-